Current understanding of the efficacy and safety of alkoxyglycerides and the refined fraction of Ecomer shark liver oil. Publication 2: Analyzing the Results of Clinical Trials
AUTHORS : Kiseleva T.L. | Kiseleva M.A.
RELEVANT UNIVERSITIES : FSBI “Research Institute of Nutrition”, Research Center NO “Professional Association naturotherapists “, Moscow
YEAR : 2014
SUMMARY From an array of bibliographic sources of varying degrees of reliability, we identified and analyzed the results of clinical studies of alkoxyglycerides (AKG), refined shark liver oil “Ecomer” (Natumin Pharma, Sweden) and crude shark liver oil. The existence of an evidence base for the use of AKG and a standardized product from liver oil of deep-sea sharks of the northern seas “Ecomer” (Ecomer®) as an immunomodulating and antitumor agent in foreign clinics has been established. We have not found the results of the use of alkoxyglycerides and the
standardized product from the liver oil of deep-sea sharks of the northern seas
“Ecomer” (Ecomer®) in domestic clinics.